| Holding | Country | Type | Rating |
|---|
| US Government | United States | Fixed Income | — | 12.6% |
| Philip Morris | United States | Equity | — | 3.6% |
| Astrazeneca | United Kingdom | Equity | — | 3.3% |
| Nestle | Switzerland | Equity | — | 2.3% |
| Broadcom | United States | Equity | — | 2.3% |
| Holding | Country | Type | Rating |
|---|
| Microsoft | United States | Equity | — | 2.1% |
| Umbs | United States | Fixed Income | — | 2.0% |
| TSMC | Taiwan | Equity | — | 2.0% |
| UnitedHealth | United States | Equity | — | 1.9% |
| Pfizer | United States | Equity | — | 1.8% |
| Sector |
|---|
| Equity | 66.1% | 100.0 |
| Energy | 3.9% | 5.9% |
| Materials | 2.2% | 3.4% |
| Industrials | 7.9% | 11.9% |
| Consumer discretionary | 5.6% | 8.5% |
| Consumer staples | 11.1% | 16.7% |
| Health care | 13.3% | 20.1% |
| Financials | 7.3% | 11.1% |
| Information technology | 10.7% | 16.3% |
| Communication services | 1.2% | 1.8% |
| Utilities | 1.5% | 2.2% |
| Real Estate | 1.4% | 2.1% |
| Fixed Income | 28.2% | 100.0 |
| Government | 21.4% | 76.0% |
| Corporate | 6.8% | 24.0% |
| Cash and equivalents | 5.7% | 100.0 |
| Name |
|---|
| North America | 58.6% |
| Europe | 22.8% |
| Emerging Markets | 6.6% |
| Japan | 4.1% |
| Asia Pacific ex Japan | 1.6% |
| Other | 0.6% |
| Cash & equivalents | 5.7% |